Yokohama
,
Japan
28 - 31 March 2026
World Congress of Nephrology (WCN 2026)
Presentation schedule and materials
Saturday, 28 March 2026
15:55
- 16:05
JST
SHORT ORAL PRESENTATION
Mechanistic kidney effects of semaglutide by baseline SGLT2i use in type 2 diabetes: a post-hoc analysis of the REMODEL trial
David Z.I. Cherney1; Radica Z. Alicic2,3; Milenta M. Chacko4; Lynette Driscoll5; Emma T.B. Olesen6; Prachi Priyardarshini7; Vikas S. Sridhar8; Katherine R. Tuttle1,2,9; Petter Bjornstad10,11
MATERIALS AVAILABLE
15:55
- 16:05
JST
POSTER
Real-world effectiveness of semaglutide and SGLT-2i vs SGLT-2i alone on kidney and cardiovascular outcomes in people with type 2 diabetes and chronic kidney disease
Edouard L. Fu, Peter Bruun-Rasmussen, David Cherney, Christine Fuchs Jacobsen, Carolien C. H. M. Maas, Manuel Maximilian Mayrdorfer, Alex Mourer, Brendon Neuen, Nils Skajaa, Katherine Tuttle
MATERIALS AVAILABLE
17:30
- 18:30
JST
P341
POSTER
Mechanistic effects of semaglutide on kidney disease in type 2 diabetes: The remodel trial
Katherine R. Tuttle,1,2; Petter Bjornstad3,4; Menno Pruijm5; Jeffrey B. Hodgin6; David Z.I. Cherney7; Nicolas Belmar8; Milenta Mariam Chacko9; Vivek Das8; Thomas Idorn8; Philip A. Schytz8; Matthias Kretzler10
MATERIALS AVAILABLE
17:30
- 18:00
JST
P324
POSTER
Effect of once-weekly semaglutide 1.0 mg on kidney outcomes by baseline characteristics: Exploratory data from the FLOW trial
Srikanth Bellary1; Richard E. Pratley2; Katherine R. Tuttle3,4; Peter Rossing5,6; Kenneth W. Mahaffey7; Prachi Priyadarshini8; Christine Sofie Fuchs Jacobsen9; Poornima K.N.8; Johannes F.E. Mann10,11
MATERIALS AVAILABLE
Keywords